MedPath

Study of thickness of tongue in patients with end stage liver disease

Not Applicable
Conditions
Health Condition 1: null- Patients with cirrhosis of liver
Registration Number
CTRI/2017/10/010103
Lead Sponsor
Manish Tandon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with cirrhosis of liver visiting hospital for treatment and Healthy Individuals visiting hospital for unrelated reasons

Exclusion Criteria

Individuals refusing participation and those with glossitis of tongue

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in Muscle mass as measured using measure of tongue between healthy and diseased individuals as a marker of sarcopenia.Timepoint: Difference in Muscle mass as measured using measure of tongue between healthy and diseased individuals as a marker of sarcopenia. Study of prevelance of sarcopenia in diffrent severity of liver diasease and correlation with outcome of disease over 6 months follow up
Secondary Outcome Measures
NameTimeMethod
Study of prevalence of sarcopenia in different severity of liver disease and correlation with outcome of disease over 6 months follow upTimepoint: First contact upon enrollment into the study and subsequent folow up of patients only and not the healthy individuals over next 6 months
© Copyright 2025. All Rights Reserved by MedPath